期刊文献+

3种抗菌药物对辛伐他汀在人肝微粒体中代谢的影响 被引量:1

Effects of 3 Kinds of Antibacterial Agents on Metabolism of Simvastatin in Human Liver Microsome
原文传递
导出
摘要 目的体外研究人肝微粒体中罗红霉素、左氧氟沙星和氟康唑分别对辛伐他汀代谢的影响。方法分别将罗红霉素、左氧氟沙星、氟康唑与辛伐他汀在人肝微粒体中共孵育,采用UPLC-MS/MS测定辛伐他汀的浓度。结果罗红霉素和左氧氟沙星对辛伐他汀的代谢没有影响,氟康唑剂量依赖性抑制辛伐他汀的代谢,其IC50值为36.6μmol·L?1。结论氟康唑显著抑制辛伐他汀的代谢,罗红霉素与左氧氟沙星对辛伐他汀在人肝微粒体中代谢无明显药物相互作用。 OBJECTIVE To study the effects of roxithromycin, levofloxacin and fluconazole on the metabolism of simvastatin in human liver microsome respectively. METHODS Simvastatin was incubated with roxithromycin, levofloxacin and fluconazole in human liver microsome. The residual concentration of simvastatin in human liver microsome incubates was determined by UPLC-MS/MS. RESULTS The roxithromycin and levofloxacin had no significant influence on the metabolism of simvastatin. The IC50 of fluconazole for the metabolism of simvastatin was 36.6 μmol·L^-1 and the inhibit intension was dose dependent. CONCLUTION The fluconazole significantly inhibits the metabolism of simvastatin. The roxithromycin and levofloxacin have no significant drug interactions on the metabolism of simvastatin.
出处 《中国现代应用药学》 CAS CSCD 2015年第11期1363-1366,共4页 Chinese Journal of Modern Applied Pharmacy
基金 常州四药临床药学科研基金(CZSYJJ11002)
关键词 辛伐他汀 人肝微粒体 超高效液相串联质谱 相互作用 simvastatin human liver microsome UPLC-MS/MS interactions
  • 相关文献

参考文献12

  • 1KASHANI A, PHILLIPS C O, FOODY J M, et al. Risks associated with statin therapy: a systematic overview of randomized clinical trims [J]. Circulation, 2006, 114(25): 2788-2797.
  • 2徐曌,柳茵,励伟芬.辛伐他汀对冠心病患者hs-CRP、MMP-9和TGF-β1的作用[J].中国现代应用药学,2014,31(6):759-762. 被引量:2
  • 3FOTI R S, ROCK D A, WIENKERS L C, et al. Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation [J]. Drug Metab Dispos, 2010, 38(6): 981-987.
  • 4BJORNSSON T D, CALLAGHAN J T, EINOLF H J, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PHRMA) perspective [J]. Drug Metab Dispos, 2003, 31 (7): 815-832.
  • 5LEWIS D F, IOANNIDES C, PARKE D V, et al. Quantitative structure-activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis [J]. Steroid Biochem Mol Biol, 2000, 74(4): 179-185.
  • 6翟学佳,刘金梅,史芳,刘亚妮,吕永宁.高效液相-质谱串联法测定大鼠血浆中辛伐他汀及辛伐他汀酸的浓度[J].中国医院药学杂志,2013,33(2):121-125. 被引量:2
  • 7王巨才,孟小惠,杨东菁,王雪芹,张建革.UPLC-MS/MS法同时测定人血浆中辛伐他汀和辛伐他汀羟基酸的浓度[J].药物分析杂志,2012,32(9):1628-1633. 被引量:1
  • 8LUCIE N, HANA V, DALIBOR S, et al. Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin [J]. J Chromatogr B, 2009, 877(22): 2093-2103.
  • 9MORITA K, KONISHI H, SHIMAKAWA H. Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in mice and humans in vivo. Comparative study with ketoconazole [J]. Chem Pharm Bull, 1992, 40(5): 1247-1251.
  • 10张沂,王洪武,费宇行,鲍燕燕,王大鹏.美托洛尔在经左氧氟沙星诱导的大鼠肝微粒体P450系统中的代谢特征[J].中国抗生素杂志,2003,28(7):418-421. 被引量:4

二级参考文献37

共引文献5

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部